Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    ino-4700 | MERS
Previous Study | Return to List | Next Study

Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04588428
Recruitment Status : Recruiting
First Posted : October 19, 2020
Last Update Posted : July 19, 2022
Coalition for Epidemic Preparedness Innovations
Information provided by (Responsible Party):
Inovio Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 15, 2024
Estimated Study Completion Date : June 15, 2024